Endpunkte klinischer Studien: Surrogatparameter oder “harte klinische Endpunkte”?

Saved in:
Bibliographic Details
Published in:Der Internist (Berlin) 2002-04, Vol.43 (4), p.493-497
Main Author: Böger, R.H.
Format: Article
Language:ger
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 497
container_issue 4
container_start_page 493
container_title Der Internist (Berlin)
container_volume 43
creator Böger, R.H.
description
doi_str_mv 10.1007/s00108-002-0559-z
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s00108_002_0559_z</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1007_s00108_002_0559_z</sourcerecordid><originalsourceid>FETCH-LOGICAL-c110t-4e5b04f5ab5ff4ba08a5a19ac4acc1b1934adc93149ebe04389db965a018b38b3</originalsourceid><addsrcrecordid>eNpNkM9KAzEQxnNQsFYfwNu-QHTGJLrxIlLqHyh4aHsOk2zWrm13l2T3YE99EH25PokpFSkM3zDMNx_Mj7ErhGsEuL-JAAg5B7jloJTmmxM2SANwrZQ8Y-cxfkLyCSUHbD6ui7avl53PlquqrqJb-JBNu76ofP2QTfsQmg_qWgq09l1aNUWS3fZ7QeH4JvvP2W1_Hi_YaUmr6C__-pDNn8ez0SufvL-8jZ4m3CFCx6VXFmSpyKqylJYgJ0WoyUlyDi1qIalwWqDU3nqQIteF1XeKAHMrUg0ZHnJdaGIMvjRtqNYUvgyC2bMwBxYmvW_2LMxG_AKLqliA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Endpunkte klinischer Studien: Surrogatparameter oder “harte klinische Endpunkte”?</title><source>Alma/SFX Local Collection</source><creator>Böger, R.H.</creator><creatorcontrib>Böger, R.H.</creatorcontrib><identifier>ISSN: 0020-9554</identifier><identifier>DOI: 10.1007/s00108-002-0559-z</identifier><language>ger</language><ispartof>Der Internist (Berlin), 2002-04, Vol.43 (4), p.493-497</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Böger, R.H.</creatorcontrib><title>Endpunkte klinischer Studien: Surrogatparameter oder “harte klinische Endpunkte”?</title><title>Der Internist (Berlin)</title><issn>0020-9554</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpNkM9KAzEQxnNQsFYfwNu-QHTGJLrxIlLqHyh4aHsOk2zWrm13l2T3YE99EH25PokpFSkM3zDMNx_Mj7ErhGsEuL-JAAg5B7jloJTmmxM2SANwrZQ8Y-cxfkLyCSUHbD6ui7avl53PlquqrqJb-JBNu76ofP2QTfsQmg_qWgq09l1aNUWS3fZ7QeH4JvvP2W1_Hi_YaUmr6C__-pDNn8ez0SufvL-8jZ4m3CFCx6VXFmSpyKqylJYgJ0WoyUlyDi1qIalwWqDU3nqQIteF1XeKAHMrUg0ZHnJdaGIMvjRtqNYUvgyC2bMwBxYmvW_2LMxG_AKLqliA</recordid><startdate>200204</startdate><enddate>200204</enddate><creator>Böger, R.H.</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>200204</creationdate><title>Endpunkte klinischer Studien: Surrogatparameter oder “harte klinische Endpunkte”?</title><author>Böger, R.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c110t-4e5b04f5ab5ff4ba08a5a19ac4acc1b1934adc93149ebe04389db965a018b38b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2002</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Böger, R.H.</creatorcontrib><collection>CrossRef</collection><jtitle>Der Internist (Berlin)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Böger, R.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Endpunkte klinischer Studien: Surrogatparameter oder “harte klinische Endpunkte”?</atitle><jtitle>Der Internist (Berlin)</jtitle><date>2002-04</date><risdate>2002</risdate><volume>43</volume><issue>4</issue><spage>493</spage><epage>497</epage><pages>493-497</pages><issn>0020-9554</issn><doi>10.1007/s00108-002-0559-z</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0020-9554
ispartof Der Internist (Berlin), 2002-04, Vol.43 (4), p.493-497
issn 0020-9554
language ger
recordid cdi_crossref_primary_10_1007_s00108_002_0559_z
source Alma/SFX Local Collection
title Endpunkte klinischer Studien: Surrogatparameter oder “harte klinische Endpunkte”?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T04%3A39%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Endpunkte%20klinischer%20Studien:%20Surrogatparameter%20oder%20%E2%80%9Charte%20klinische%20Endpunkte%E2%80%9D?&rft.jtitle=Der%20Internist%20(Berlin)&rft.au=B%C3%B6ger,%20R.H.&rft.date=2002-04&rft.volume=43&rft.issue=4&rft.spage=493&rft.epage=497&rft.pages=493-497&rft.issn=0020-9554&rft_id=info:doi/10.1007/s00108-002-0559-z&rft_dat=%3Ccrossref%3E10_1007_s00108_002_0559_z%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c110t-4e5b04f5ab5ff4ba08a5a19ac4acc1b1934adc93149ebe04389db965a018b38b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true